Why is this trending?
Crossbow Therapeutics raised $77 million in Series B funding to advance TCR-mimetic cancer immunotherapies. Separately, police arrested a suspect in a West Virginia crossbow shooting incident.
Sign in to join the conversation
Log in to chat